AFT Pharmaceuticals (ASX:AFP) growth continues despite Covid-19

Latest Company News - Finance News Network

English - November 18, 2020 21:30 - 1000 KB
Business News News Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed

Previous Episode: CIMIC Groups (ASX:CIM) CPB Contractor's win $800 million contract

Next Episode: Immutep Limited (ASX:IMM) completes $29.6m placement to expand clinical development

19 Nov 2020 - AFT Pharmaceuticals (ASX:AFP) reports continued growth in revenue and normalised earnings as it benefits from growth across its portfolio of over-the-counter and prescription medicines.